Sponsors

We are grateful to our sponsors for their support to this conference and to the Society of fNIRS!!!

Supported by National Institute of Health

NIH support came as a R13 grant. Dr Franceschini is the PI of that grant and she is running the conference. Hence she has to disclose her conflict of interest.

 Dr. Maria A. Franceschini has a financial interest in 149 Medical, Inc. This company is developing diffuse correlation spectroscopy (DCS) technology for assessing and monitoring cerebral blood flow (CBF) in newborn infants. Dr. Franceschini’s interests were reviewed and are managed by Mass General Hospital, and Mass General Brigham in accordance with their conflict of interest policies 

Exhibitors

SOLD OUT

for waiting list

Artinis

Biopac

Boston Electronics

Cortivision

Gowerlabs

ISS

Hamamatsu

Neuluce


NIRx

Obelab

OptoElectronics Components

PioNIRS

Rogue

Seenel Imaging

Spectratech/VOX Biomedical

TechEn